18194-24-6

18194-24-6 is a lipid of Glycerophospholipids (GP) class. 18194-24-6 is associated with abnormalities such as Cerebrovascular accident, Renal tubular disorder, Atherosclerosis, Hyperlipoproteinemia Type III and Lipid Metabolism Disorders. The involved functions are known as Process, protein folding, Catalyst, Biochemical Pathway and Fold in Medical Device Material. 18194-24-6 often locates in Tissue membrane, Membrane, periplasm, vesicle membrane and outer membrane. The associated genes with 18194-24-6 are Integral Membrane Proteins, Protein Structure, RTN4 gene, RTN4R gene and Protein, Organized by Structure. The related lipids are Micelles, dimyristoylphosphatidylglycerol, 1,2-dihexadecyl-sn-glycero-3-phosphocholine, Unilamellar Vesicles and cholesteryl oleate. The related experimental models are Mouse Model, Arthritis, Adjuvant-Induced, Disease model and Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of 18194-24-6, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 18194-24-6?

18194-24-6 is suspected in Atherosclerosis, Cardiovascular Diseases, Dehydration, Abnormal shape, Renal tubular disorder, Hyperlipoproteinemia Type III and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 18194-24-6

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Body Weight D001835 333 associated lipids
Carcinoma D002277 18 associated lipids
Osteosarcoma D012516 50 associated lipids
Lymphoma, Large B-Cell, Diffuse D016403 13 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Alzheimer Disease D000544 76 associated lipids
Arteriosclerosis D001161 86 associated lipids
Per page 10 20 50 | Total 22

PubChem Associated disorders and diseases

What pathways are associated with 18194-24-6

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 18194-24-6?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 18194-24-6?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 18194-24-6?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 18194-24-6?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 18194-24-6?

Mouse Model

Mouse Model are used in the study 'Association of a model class A (apolipoprotein) amphipathic alpha helical peptide with lipid: high resolution NMR studies of peptide.lipid discoidal complexes.' (Mishra VK et al., 2006).

Arthritis, Adjuvant-Induced

Arthritis, Adjuvant-Induced are used in the study 'T cell antigen receptor peptide-lipid membrane interactions using surface plasmon resonance.' (Bender V et al., 2004).

Disease model

Disease model are used in the study 'Kupffer cells do not play a role in governing the efficacy of liposomal mitoxantrone used to treat a tumor model designed to assess drug delivery to liver.' (Lim HJ et al., 2000).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with 18194-24-6

Download all related citations
Per page 10 20 50 100 | Total 3218
Authors Title Published Journal PubMed Link
Lee JW and Kim H Fragmentation of dimyristoylphosphatidylcholine vesicles by apomyoglobin. 1992 Arch. Biochem. Biophys. pmid:1497354
Manning M and Griffith J Association of M13 I-forms and spheroids with lipid vesicles. 1985 Arch. Biochem. Biophys. pmid:3966795
Lai CS and Cheng SY Molecular dynamics of 3,3',5-triiodo-L-thyronine in model membranes: a spin label study. 1984 Arch. Biochem. Biophys. pmid:6087728
Konopka K and Waskell L Modification of trypsin-solubilized cytochrome b5, apocytochrome b5, and liposome-bound cytochrome b5 by diethylpyrocarbonate. 1988 Arch. Biochem. Biophys. pmid:3341778
Bayburt TH et al. Assembly of single bacteriorhodopsin trimers in bilayer nanodiscs. 2006 Arch. Biochem. Biophys. pmid:16620766
Momo F et al. Interaction of linear mono- and diamines with dimyristoylphosphatidylcholine and dimyristoylphosphatidylglycerol multilamellar liposomes. 2000 Arch. Biochem. Biophys. pmid:11068873
Yin JJ et al. Effects of fumonisin B1 and (hydrolyzed) fumonisin backbone AP1 on membranes: a spin-label study. 1996 Arch. Biochem. Biophys. pmid:8914830
Vidić B and Obcemea CH Scanning tunneling microscopic (STM) analysis of the phospholipid bilayer surface characteristics in the P beta phase. Secondary ripples. 1992 Arch. Histol. Cytol. pmid:1290674
Van Tornout P et al. Association of apoproteins with cholesterol-phospholipid vesicles [proceedings]. 1979 Arch. Int. Physiol. Biochim. pmid:94786
Hanssens I et al. Interaction between DMPC-vesicles and the peripheral protein alpha-lactalbumin [proceedings]. 1979 Arch. Int. Physiol. Biochim. pmid:94790
Catalá A The interaction of albumin and fatty-acid-binding protein with membranes: oleic acid dissociation. 1984 Arch. Int. Physiol. Biochim. pmid:6084491
Reddy ST et al. Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse models. 2004 Arterioscler. Thromb. Vasc. Biol. pmid:15242861
Huang W et al. A single amino acid deletion in the carboxy terminal of apolipoprotein A-I impairs lipid binding and cellular interaction. 2000 Arterioscler. Thromb. Vasc. Biol. pmid:10634820
Anantharamaiah GM et al. Use of synthetic peptide analogues to localize lecithin:cholesterol acyltransferase activating domain in apolipoprotein A-I. 1990 Jan-Feb Arteriosclerosis pmid:2105091
Sakai M et al. Reconstituted high density lipoprotein reduces the capacity of oxidatively modified low density lipoprotein to accumulate cholesteryl esters in mouse peritoneal macrophages. 1996 Atherosclerosis pmid:8808496
Stannard AK et al. Apolipoprotein E and regulation of cytokine-induced cell adhesion molecule expression in endothelial cells. 1998 Atherosclerosis pmid:9699892
Huang W et al. Recombinant proapoA-I(Lys107del) shows impaired lipid binding associated with reduced binding to plasma high density lipoprotein. 2001 Atherosclerosis pmid:11689210
Ghiselli G et al. Binding of apoA-IV-phospholipid complexes to plasma membranes of rat liver. 1986 Biochem. Biophys. Res. Commun. pmid:3767949
Brunner E et al. Molecular alignment of proteins in bicellar solutions: quantitative evaluation of effects induced in 2D COSY spectra. 2000 Biochem. Biophys. Res. Commun. pmid:10860817
Grammenos A et al. Quantification of Randomly-methylated-beta-cyclodextrin effect on liposome: an ESR study. 2009 Biochem. Biophys. Res. Commun. pmid:19744466